Babak Azad - 08 Dec 2022 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Marketing Officer and SVP, Marketing & Communications
Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Babak Azad, Gracye Cheng, as Attorney-in-Fact for Babak Azad
Issuer symbol
GDRX
Transactions as of
08 Dec 2022
Net transactions value
-$35,134
Form type
4
Filing time
12 Dec 2022, 16:19:58 UTC
Previous filing
26 Sep 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +20,401 +408% 25,401 08 Dec 2022 Direct F1
transaction GDRX Class A Common Stock Tax liability $35,134 -7,055 -28% $4.98 18,346 08 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -20,401 -6.2% $0.000000 306,023 08 Dec 2022 Class A Common Stock 20,401 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximtely equal quarterly installments thereafter for 15 quarters.

Remarks:

Chief Marketing Officer and SVP, Marketing & Communications